Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF AUGUST 25, 2013 FBO #4292
SOLICITATION NOTICE

65 -- Ovation SP Ultralow DR Multiplex kits and Cartridges - Package #1

Notice Date

8/23/2013
 

Notice Type

Presolicitation
 

NAICS

325199 — All Other Basic Organic Chemical Manufacturing
 

Contracting Office

Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
 

ZIP Code

20892-7902
 

Solicitation Number

HHS-NIH-NHLBI-CSB-(HL)-2013-224-DDC
 

Archive Date

9/11/2013
 

Point of Contact

Deborah - Coulter, Phone: (301) 435-0368
 

E-Mail Address

dc143b@nih.gov
(dc143b@nih.gov)
 

Small Business Set-Aside

N/A
 

Description

Justification and approval (J&A) INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisition (OA) on behalf of the of the DNA Sequencing & Genomics Core, (NHLBI), intends to negotiate and award a purchase order on a noncompetitive sole source basis without providing for full and open competition to NuGen Technologies, Inc., 201Industrial Road, Suite 310,San Carlos, CA94070 to procure NuGen Technologies Kits. Procurement: The vendor will provide the Government the following products: *OvationSP Ultralow DR Multiplex System 1-8 Quantity of 24 kits Catalog# 8033-32 Containing 8 unique barcoded adaptors for multiplex sequencing per kit Agencourt RNAClean XP beads Sample Concentration Solution *Mondrian SP+ Workstation Quantity 1 Workstation Catalog# 8100 * Contractor shall provide a letter from the manufacturer stating they are in authorized reseller Background: The mission of the DIR DNA Sequencing and Genomics Core is to provide the NHLBI DIR investigators with cutting -edge sequencing technology to meet the increasing demands in genomics and epigenomics research. The NuGen Ovation SP Ultralow DR Multiplex kits are needed for the Framingham Heart Study (FHS) pilot RNA-Seq project. This project aims to obtain a deeper understanding of the CVD (cardiovascular disease) risk loci, which had been previously identified by genome-wide association study (GWAS). This will be achieved by characterizing patient transcriptome using the state-of-the-art RNA-Seq procedure. Transcriptome data will be analyzed primarily in CAD cases, including individuals with prior MI, other manifestations of CAD, and/or with high coronary artery calcium levels and in controls. Since the FHS RNA samples are precious specimen and are in very low quantity. These samples have to be pre-amplified before standard library construction. The NuGen Ovation kits requested serve as the critical reagent to generate double stranded cDNA from RNA samples with limited quantity. Based on a proprietary SPIA (single primer isothermal amplification) technique, the Ovation kit can yield microgram of double stranded cDNAs from nanogram and even subnanogram input of RNAs. Therefore, it is indispensable for the experimental implementation of the FHS RNA-Seq project, which is of great interest to NIH mission and health of the general public. Purpose and Objective: DIR DNA Sequencing and Genomics Core is to provide the NHLBI DIR investigators with cutting -edge sequencing technology to meet the increasing demands in genomics and epigenomics research. The core facility fulfills this need using NuGen Technology products. These instruments are responsible for high-throughput data acquisition. Before Sequencing can begin a high quality DNA Library must be constructed. NuGen Technologies provides the Mondrian, a high quality and through- put instrument to accomplish this task. The Ovation SP Ultralow DR Multiplex System is the reagent system designed for use with the Mondrian. These reagents provide automated production of multiplexed libraries starting with as little as 1ng of DNA. This acquisition is paramount to the Cores ability to provide this service the Institute, The DIR Sequencing and Genomics Core provides NextGen sequencing services to more than 20 DIR Laboratories. Without the reagents to perform Library construction, DNA sequencing is not possible. Anticipated Delivery: Reagents will be separated into two shipments as follows: • Shipment #1 within 30 days after receipt of order • Shipment #2 30 calendar days after shipment 1 Government Responsibilities: NHLBI, DNA Sequencing and Genomics Core will ensure receiving of the kits, along with storage at 4C under proper conditions. Will ensure the kits are used within the proper timeline before the expiration date. Ensure the Mondrian SP Workstation is received without damage, set up and tested within 4 weeks of receipt Inspection and Acceptance Requirements: Inspection and acceptance of reagents and instrumentation will be performed at the NIH/NHLBI DNA Sequencing and Genomics Core, located in the CRC, building 10, Room 8N115, Bethesda, MD 20892. Any questions or concerns will be addressed with the medical director of the pulmonary function lab and with the vendor. If there is significant damage to the packaging, representing deep penetration or water damage, or if there is evidence of tampering with the contents, then the shipment should be rejected. The medical director or his/her designee will communicate this decision to the sales representative of the vendor Justification: Refer to attached Justification and Approval Regulatory Authority: This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1(b) Soliciting from a single source, only one responsible source and no other supplies or services will satisfy agency requirements. ADDITIONAL INFORMATION Industry Classification (NAICS) Code is 325199, All Other Basic Organic Chemical Manufacturing Services and the Small Business Size Standard is 1000 employees. The acquisition is being conducted under FAR Part 13, simplified acquisition procedures, therefore the requirements of FAR Part 6 B Competitive Requirements are not applicable (FAR Part 6.001). The resultant Contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-69 (August 1st 2013). This requirement is under the SAT of $150,000.00. This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by August 27, 2013, 9:00 am eastern standard time and must reference synopsis number HHS-NIH- NHLBI-CSB-(HL)-2013-224-DDC, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6142, Bethesda, Maryland 20892-7902, Attention: Deborah Coulter. Response may be submitted electronically to coulterd@nhlbi.nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/HHS-NIH-NHLBI-CSB-(HL)-2013-224-DDC/listing.html)
 

Place of Performance

Address: NIH, Bethesda, Maryland, 20892, United States

Zip Code: 20892
 

Record

SN03160964-W 20130825/130824000125-da7fd08a9fe8a53c159cf067e60fd043 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |